Related Experiment Video
Updated: Oct 19, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells
Ying Wang1, Xiaoli Li1, Shuyue Wang2
1National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, China.
Abstract:
Cripto-1 is highly expressed in many cancers, and downregulating its expression may become a promising approach for cancer treatment. However, the regulation of Cripto-1 expression is not well characterized. In this study, we focused on the post-transcriptional regulation of Cripto-1 expression and analyzed the potential miRNAs that bind to the 3'UTR of Cripto-1 mRNA. miR-3929 was found to be able to bind to the 3'UTR and downregulate the expression of Cripto-1 in cervical cancer cells. Then, we analyzed the effect of miR-3929 on the biological behavior of cervical cancer cells, finding that miR-3929 could reduce cell viability, DNA synthesis, and Ki67 expression and induce cell cycle arrest in the G2/M phase; overexpression of Cripto-1 reversed the inhibitory effect of miR-3929 on proliferation. Moreover, DAPI staining and flow cytometry revealed that miR-3929-induced cell apoptosis is dependent on the mitochondrial pathway; the overexpression of Cripto-1 reversed the proapoptotic effect of miR-3929. Finally, the in vivo results showed that miR-3929 significantly inhibits the growth of HeLa xenograft tumors in nude mice. Therefore, our findings suggest that miR-3929 inhibits the proliferation and induces the apoptosis of cervical cancer cells by downregulating Cripto-1 via specifically targeting the 3'UTR of its mRNA.
Insights
MicroRNA-3929 (miR-3929) inhibits cervical cancer progression by targeting Cripto-1. This microRNA reduces tumor growth, proliferation, and induces apoptosis, offering a potential therapeutic strategy for cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cripto-1 is overexpressed in various cancers, making its downregulation a potential cancer treatment strategy.
- The post-transcriptional regulation of Cripto-1 expression, particularly by microRNAs, is not well understood.
Purpose of the Study:
- To investigate the post-transcriptional regulation of Cripto-1 expression by microRNAs.
- To analyze the role of miR-3929 in regulating Cripto-1 expression and its impact on cervical cancer cell behavior.
Main Methods:
- Bioinformatic analysis to predict miRNAs targeting Cripto-1 mRNA 3'UTR.
- In vitro studies using cervical cancer cells to assess the effects of miR-3929 and Cripto-1.
- In vivo studies using HeLa xenograft models in nude mice.
Main Results:
- miR-3929 directly binds to the 3'UTR of Cripto-1 mRNA and downregulates its expression in cervical cancer cells.
- miR-3929 inhibits cervical cancer cell viability, DNA synthesis, and Ki67 expression, inducing G2/M phase cell cycle arrest.
- miR-3929 promotes apoptosis via the mitochondrial pathway, an effect reversed by Cripto-1 overexpression.
- In vivo, miR-3929 significantly inhibits the growth of HeLa xenograft tumors.
Conclusions:
- miR-3929 acts as a tumor suppressor in cervical cancer by downregulating Cripto-1.
- Targeting Cripto-1 with miR-3929 presents a promising therapeutic avenue for cervical cancer treatment.
Related Concept Videos
MicroRNAs
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Experimental RNAi
Abnormal Proliferation
Negative Regulator Molecules

